These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 18760949)

  • 1. [Platelet-leukocyte aggregates as a marker for platelet activation in platelet concentrates].
    Chakroun T; Abdelkefi S; Bouslama M; Houissa B; Zaier M; Miled A; Kortas M; Yacoub S
    Transfus Clin Biol; 2008 Sep; 15(4):148-53. PubMed ID: 18760949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
    Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
    Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters.
    Dijkstra-Tiekstra MJ; Pietersz RN; Huijgens PC
    Vox Sang; 2004 Nov; 87(4):257-63. PubMed ID: 15585021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
    Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
    Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
    Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
    Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].
    Bux J; Müller K; Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():99-102. PubMed ID: 1703912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
    Sandgren P; Hansson M; Gulliksson H; Shanwell A
    Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
    Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
    Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of preparation and preservation modality on thrombocyte quality].
    Mohren M; Müller H; Körner K; Wiesneth M; Kubanek B; Heimpel H; Seifried E
    Beitr Infusionsther; 1993; 31():107-10. PubMed ID: 7693237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in platelet concentrates from dogs due to storage. I. Platelet count in in vitro function].
    Klein A; Adamik A; Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(6-7):243-53. PubMed ID: 10472723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.